Trials / Conditions / Allogeneic Stem Cell Transplant Recipient
Allogeneic Stem Cell Transplant Recipient
3 registered clinical trials studyying Allogeneic Stem Cell Transplant Recipient — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Maligna NCT07214688 | Hackensack Meridian Health | Phase 2 |
| Withdrawn | Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplantat NCT04127721 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Trial Testing Safety of IL-21 NK Cells for Induction of R/R AML NCT04220684 | Sumithira Vasu | Phase 1 |